Advertisement

Journal of Materials Science: Materials in Medicine

, Volume 24, Issue 11, pp 2659–2663 | Cite as

A road map for a tissue engineering concept for restoring structure and function after limb loss

  • Dietmar W. Hutmacher
Article

Introduction

In the 21st century the focus of tissue engineering/regenerative medicine (TE/RM) strategies did change its aim from repair to regeneration [1, 2, 3, 4]. In concert, interdisciplinary teams composed of scientists, engineers and clinicians in the field of TE/RM are now applying the principles of cell transplantation, biomaterial science, and bioengineering to design and fabricate tissue engineered constructs (TEC) that can restore and maintain normal function in diseased and injured tissues [5, 6].

In biology, regeneration is the process of renewal and restoration that makes genomes, cells, tissues, and organs, resilient to natural fluctuations or events that cause trauma and/or injury [7]. The benchmark for tissue engineers working on limb regeneration is the newt. For example, an adult salamander can regenerate a lost arm or leg over and over again; regardless of how many times the part is amputated [8].

Frogs can regenerate a limb during tadpole stages when their limbs...

Keywords

Tissue Engineering Regenerative Medicine Tissue Interface Limb Loss Opinion Paper 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Griffith LG, Naughton G. Tissue engineering: current challenges and expanding opportunities. Science. 2002;295(5557):1009–14. doi: 10.1126/science.1069210.CrossRefGoogle Scholar
  2. 2.
    Woodruff MA, Hutmacher DW. The return of a forgotten polymer: polycaprolactone in the 21st century. Prog Polym Sci. 2010;35(10):1217–56.CrossRefGoogle Scholar
  3. 3.
    Lavik E, Langer R. Tissue engineering: current state and perspectives. Appl Microbiol Biotechnol. 2004;65(1):1–8. doi: 10.1007/s00253-004-1580-z.CrossRefGoogle Scholar
  4. 4.
    Khademhosseini A, Vacanti JP, Langer R. Progress in Tissue Engineering. Sci Am. 2009;300(5):64.CrossRefGoogle Scholar
  5. 5.
    Lysaght MJ, Jaklenec A, Deweerd E. Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics. Tissue Eng A. 2008;14(2):305–15. doi: 10.1089/tea.2007.0267.CrossRefGoogle Scholar
  6. 6.
    Pangarkar N, Pharoah M, Nigam A, Hutmacher DW, Champ S. Advanced Tissue Sciences Inc.: learning from the past, a case study for regenerative medicine. Regen Med. 2010;5(5):823–35. doi: 10.2217/rme.10.66.CrossRefGoogle Scholar
  7. 7.
    Holden C. Regenerative medicine: rebuilding the injured warrior. Science. 2008;320(5875):437. doi: 10.1126/science.320.5875.437a.CrossRefGoogle Scholar
  8. 8.
    Eguchi G, Eguchi Y, Nakamura K, Yadav MC, Millan JL, Tsonis PA. Regenerative capacity in newts is not altered by repeated regeneration and ageing. Nat Commun. 2011;2:384. doi: 10.1038/ncomms1389.CrossRefGoogle Scholar
  9. 9.
    Blau HM, Pomerantz JH. Re”evolutionary” regenerative medicine. JAMA. 2011;305(1):87–8. doi: 10.1001/jama.2010.1938.CrossRefGoogle Scholar
  10. 10.
    Probst FA, Hutmacher DW, Muller DF, Machens HG, Schantz JT. Calvarial reconstruction by customized bioactive implant. Handchir Mikrochir Plast Chir. 2010;42(6):369–73. doi: 10.1055/S-0030-1248310.CrossRefGoogle Scholar
  11. 11.
    Service RF. Tissue engineering. Coming soon to a knee near you: cartilage like your very own. Science. 2008;322(5907):1460–1. doi: 10.1126/science.322.5907.1460.CrossRefGoogle Scholar
  12. 12.
    Malda J, Visser J, Melchels FP, Jüngst T, Hennink WE, Dhert WJ, et al. 25th anniversary article: engineering hydrogels for biofabrication. Adv Mater. 2013. doi: 10.1002/adma.201302042.Google Scholar
  13. 13.
    Mason C. Regenerative medicine 2.0. Regen Med. 2007;2(1):11–8. doi: 10.2217/17460751.2.1.11.CrossRefGoogle Scholar
  14. 14.
    Qutachi O, Shakesheff KM, Buttery LD. Delivery of definable number of drug or growth factor loaded poly (DL-lactic acid-co-glycolic acid) microparticles within human embryonic stem cell derived aggregates. J Control Release. 2013;168(1):18–27. doi: 10.1016/j.jconrel.2013.02.029.CrossRefGoogle Scholar
  15. 15.
    Yang PJ, Temenoff JS. Engineering orthopedic tissue interfaces. Tissue Eng Part B Rev. 2009;15(2):127–41. doi: 10.1089/ten.teb.2008.0371.CrossRefGoogle Scholar
  16. 16.
    Muschler GE, Nakamoto C, Griffith LG. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg. 2004;86A(7):1541–58.Google Scholar
  17. 17.
    Reichert JC, Saifzadeh S, Wullschleger ME, Epari DR, Schutz MA, Duda GN, et al. The challenge of establishing preclinical models for segmental bone defect research. Biomaterials. 2009;30(12):2149–63. doi: 10.1016/j.biomaterials.2008.12.050.CrossRefGoogle Scholar
  18. 18.
    Woodruff MA, Lange C, Reichert J, Berner A, Chen F, Fratzl P, et al. Bone tissue engineering: from bench to bedside. Mater Today. 2012;15(10):430–5.CrossRefGoogle Scholar
  19. 19.
    Giannoudis P, Pountos I. Tissue regeneration. The past, the present and the future. Injury. 2005;36(Suppl 4):S2–5.CrossRefGoogle Scholar
  20. 20.
    Jaklenec A, Stamp A, Deweerd E, Sherwin A, Langer R. Progress in the tissue engineering and stem cell industry “are we there yet?”. Tissue Eng Part B Rev. 2012;18(3):155–66. doi: 10.1089/ten.TEB.2011.0553.CrossRefGoogle Scholar
  21. 21.
    Holzapfel BM, Reichert JC, Schantz JT, Gbureck U, Rackwitz L, Noth U, et al. How smart do biomaterials need to be? A translational science and clinical point of view. Adv Drug Deliv Rev. 2012;. doi: 10.1016/j.addr.2012.07.009.Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Science and Engineering Faculty, Regenerative Medicine Institute of Health and Biomedical InnovationQueensland University of TechnologyBrisbaneAustralia

Personalised recommendations